<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04129619</url>
  </required_header>
  <id_info>
    <org_study_id>OM-201</org_study_id>
    <nct_id>NCT04129619</nct_id>
  </id_info>
  <brief_title>A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)</brief_title>
  <official_title>A Double-Blind, Placebo-Controlled, Phase 2, Responsive Adaptive Randomization Study of ORP-101 in Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>OrphoMed, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>PPD</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>OrphoMed, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the effects of ORP-101 versus placebo on stool consistency and
      abdominal pain in patients with Irritable Bowel Syndrome with Diarrhea (IBS-D). It will also
      assess the safety and tolerability of ORP-101 in patients with IBS-D.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objectives of this study are to evaluate the efficacy, safety and tolerability of ORP-101
      in patients with IBS-D. This is a randomized, double-blind, placebo-controlled, 3-arm,
      12-week, parallel proof-of-concept study with 2 active arms (50 mg and 100 mg ORP-101, QD)
      and 1 matching placebo arm, using a responsive adaptive randomization approach. After
      screening, patients who qualify will enter the baseline symptom assessment period, during
      which they will be instructed on completion of an electronic diary for daily collection of
      data related to their IBS symptoms, bowel function and loperamide rescue usage (not allowed
      during baseline).

      Patients who meet all entry criteria will be randomized to receive one of two different doses
      of ORP-101 tablets or placebo for 12 weeks. The study drug will be taken once daily,
      approximately 30 minutes prior to breakfast. Patients will return to the clinic on Days 14,
      28, 56, 84 (12 weeks) and 2 weeks after dosing has completed (Day 98) for a follow-up visit.

      Study subjects will include both male and female adults. Approximately 320 patients with
      IBS-D will be randomized to receive study drug or placebo. Randomization will be stratified
      by history of cholecystectomy/gallbladder agenesis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 22, 2019</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Participants Who Are Composite Responders Based on Improvements From Baseline in Daily Worst Abdominal Pain and Daily Stool Consistency Scores</measure>
    <time_frame>Week 12</time_frame>
    <description>Composite responders are defined as participants who met the daily response criteria for at least 50% of the days with diary entries over the 12-week interval. A participant must meet both of the following criteria on a given day to be a daily responder: 1) Daily pain response: worst abdominal pain scores in the past 24 hours improved by ≥30% compared to baseline (average of daily worst abdominal pain the week prior to randomization). 2) Average of daily stool consistency response for all reported bowel movements on the specific day: Bristol Stool Scale (BSS) score &lt;5 (ie, score of 1, 2, 3, or 4) or the absence of a bowel movement if accompanied by ≥30% improvement in worst abdominal pain compared to baseline pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Who Are Responders in Daily Worst Abdominal Pain Scores</measure>
    <time_frame>Week 12</time_frame>
    <description>Pain responders over the interval from Weeks 1-12 are defined as those patients who meet the daily pain response criteria for at least 50% of days with diary entry during the interval. To be eligible to be a responder, a patient must have a minimum of 60 days of diary entries over the 12-week interval.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Who Are Responders in Daily Stool Consistency Scores</measure>
    <time_frame>Baseline to Week 12</time_frame>
    <description>Stool consistency responders over the interval from Weeks 1-12 are defined as those patients who meet the daily stool consistency response criteria for at least 50% of days with diary entry during the interval. To be eligible to be a responder, a patient must have a minimum of 60 days of diary entries over the 12-week interval.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Who are Responders in IBS Global Symptom Scores</measure>
    <time_frame>Week 12</time_frame>
    <description>IBS Global Symptom Score: Change from baseline for interval from Weeks 1-12: A responder is defined as a patient who has an IBS global symptom score of 0 (none) or 1 (mild) or daily IBS symptom score improved by ≥ 2.0 compared to the average in the week prior to randomization. A minimum of 60 days of diary entries over the 12-week interval is required for responders.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Who are Responders in IBS Adequate Relief Scores</measure>
    <time_frame>Week 12</time_frame>
    <description>IBS Adequate Relief: Percent of responders over the interval from Weeks 1-12. Responders are defined as those patients with a weekly response of &quot;Yes&quot; to adequate relief of their IBS symptoms for at least 50% of the total weeks during the interval.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Who Are Modified Composite Responders Based on Responder Endpoints</measure>
    <time_frame>Week 12</time_frame>
    <description>A modified composite responder endpoint in which a daily responder will be defined as having both: 1) Pain response: worst abdominal pain score in the past 24 hours improved ≥ 30% compared to the average in the week prior to randomization. 2) Stool consistency response: all bowel movements on the specific day must have BSFS score &lt; 5 or the absence of a bowel movement if accompanied by ≥ 30% improvement in worst abdominal pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Daily Abdominal Discomfort Scores</measure>
    <time_frame>Week 12</time_frame>
    <description>Discomfort: Change from baseline in daily abdominal discomfort scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Daily Abdominal Bloating Scores</measure>
    <time_frame>Week 12</time_frame>
    <description>Bloating: Change from baseline in daily abdominal bloating scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Bowel Movements Per Day</measure>
    <time_frame>Week 12</time_frame>
    <description>Frequency: Change from baseline in mean number of bowel movements per day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Bowel Incontinence Free Days</measure>
    <time_frame>Week 12</time_frame>
    <description>Change from baseline in mean number of bowel incontinence episodes per day as well as the number of incontinence-free days</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">320</enrollment>
  <condition>Irritable Bowel Syndrome With Diarrhea</condition>
  <arm_group>
    <arm_group_label>ORP-101 50 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ORP-101 (50 mg) once daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ORP-101 100 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ORP-101 (100 mg), once daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Matching placebo, once daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ORP-101</intervention_name>
    <description>Oral tablet</description>
    <arm_group_label>ORP-101 100 mg</arm_group_label>
    <arm_group_label>ORP-101 50 mg</arm_group_label>
    <other_name>dibuprenorphine-ethyl-ether</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Oral tablet</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Willing and able to comply with protocol, including completion of electronic daily
             diary as required.

          -  Has a diagnosis of IBS-D (Irritable Bowel Syndrome with Diarrhea) and meets the Rome
             IV Criteria, by history, for both IBS and IBS-D.

          -  Has abdominal pain intensity score, and stool consistency as determined by protocol
             and assessed by Investigator for the week prior to randomization.

          -  Has not used loperamide within the 14 days prior to randomization.

          -  Is on a stable diet for the past 12 weeks and is not planning to change lifestyle
             and/or diet during study.

        Exclusion Criteria:

          -  History of clinically relevant pancreatic conditions including pancreatitis, pancreas
             divisum, or Sphincter of Oddi (SO) dysfunction with pancreatic manifestations.

          -  History of biliary pathology including acute cholecystitis within 6 months or biliary
             pain including post-cholecystectomy pain.

          -  Patients who have had biliary sphincterotomy with post-procedure persistent abnormal
             liver function transaminases (LFTs).

          -  Planned elective surgery within the next 4 months.

          -  Significant and/or severe medical illnesses such as cardiovascular, neurological,
             infectious, renal, hepatic or respiratory disorders that would interfere with the
             patient's medical care, participation in, or conduct of the study.

          -  History of intestinal obstruction, stricture, toxic megacolon, GI (gastro-intestinal)
             perforation, fecal impaction, gastric banding, bariatric surgery, adhesions, ischemic
             colitis, or impaired intestinal circulation (e.g. aorto-iliac disease).

          -  History of lactose intolerance uncontrolled on a lactose-free diet, or other
             malabsorption syndromes (e.g. fructose malabsorption).

          -  Dysphagia or difficulty swallowing pills.

          -  History of inflammatory bowel disease, celiac disease, Clostridium difficile colitis
             or have had recent unexplained GI bleeding within 3 months prior to screening.

          -  History of major gastric, hepatic, pancreatic or intestinal surgery (appendectomy,
             hemorrhoidectomy, or polypectomy allowed as long as occurred &gt; 3 months prior to trial
             screening; uncomplicated laparoscopic or open cholecystectomy is allowed if no history
             of post-operative biliary tract pain and surgery occurred &gt; 3 months prior to
             screening).

          -  Patients &gt;40 years of age at high risk for colon cancer must have had a screening
             colonoscopy within the past 3 years prior to trial screening visit or &gt; 50 years of
             age, must have had a normal screening colonoscopy within the past 10 years prior to
             trial screening visit. Patients with Lynch Syndrome or Familial Polyposis are excluded
             from the study.

        Other protocol-defined inclusion/exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sowmya Krishnamurthy</last_name>
    <phone>Please email:</phone>
    <email>sowmya.krishnamurthy@ppdi.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lynsey Nagrani</last_name>
    <phone>Please email:</phone>
    <email>lynsey.nagrani@ppdi.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Achieve Clinical Research (Site 155)</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kaytie Aycock</last_name>
      <phone>205-757-8212</phone>
      <email>kaycock@accelclinical.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Synexus Clinical Research US, Inc. - Phoenix Southeast (Site 123)</name>
      <address>
        <city>Chandler</city>
        <state>Arizona</state>
        <zip>85224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Gray</last_name>
      <phone>408-775-1115</phone>
      <email>Stephanie.Gray@synexus-us.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Elite Clinical Studies - Phoenix (Site 116)</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85018</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Otutoa</last_name>
      <phone>602-788-3437</phone>
      <email>rebecca@eliteclinicalstudies.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Del Sol Research Management - BTC (Site 165)</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anitza Garcia</last_name>
      <phone>520-257-3881</phone>
      <email>anitzagarcia@delsolresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Synexus Clinical Research US, Inc. - Orange Grove Family Practice (Site 118)</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85741</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karin Allred</last_name>
      <phone>520-333-4515</phone>
      <email>Karin.Allred@synexus-us.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Del Sol Research Management - BTC (Site 130)</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85745</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nayeli Lopez</last_name>
      <phone>520-257-3881</phone>
      <email>nlopez@delsolresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Preferred Research Partners - ClinEdge (Site 103)</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>LeeAnne Morgan</last_name>
      <phone>501-553-9987</phone>
      <email>lmorgan@preferredresearchpartners.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Applied Research Center (Site 158)</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donna Wright</last_name>
      <phone>501-954-7822</phone>
      <email>donna@arcarkansas.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Connecticut Clinical Research Foundation (Site 136)</name>
      <address>
        <city>Bristol</city>
        <state>Connecticut</state>
        <zip>06010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Salam Zakko</last_name>
      <phone>860-585-3838</phone>
      <email>szakko@connecticutgi.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Imagine Research of Palm Beach County (Site 187)</name>
      <address>
        <city>Boynton Beach</city>
        <state>Florida</state>
        <zip>33435</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jack Herman</last_name>
      <phone>561-822-7007</phone>
      <email>jack@imagineresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Meridien Research - Lakeland (Site 167)</name>
      <address>
        <city>Lakeland</city>
        <state>Florida</state>
        <zip>33803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Colleen Figueroa</last_name>
      <phone>863-940-2087</phone>
      <email>cfigueroa@meridienresearch.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Precision Clinical Research LLC (Site 139)</name>
      <address>
        <city>Lauderdale Lakes</city>
        <state>Florida</state>
        <zip>33319</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nigam Parikh</last_name>
      <phone>954-915-9991</phone>
      <email>parikhgpmd@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Meridien Research, Maitland - Inpatient (Site 141)</name>
      <address>
        <city>Maitland</city>
        <state>Florida</state>
        <zip>32751</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacey Westover</last_name>
      <phone>407-644-1165</phone>
      <email>swestover@meridienresearch.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oviedo Medical Research (Site 140)</name>
      <address>
        <city>Oviedo</city>
        <state>Florida</state>
        <zip>32765</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>LeiAn Diaz</last_name>
      <phone>407-977-0275</phone>
      <email>leian@oviedomedicalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Research Center of Florida (Site 186)</name>
      <address>
        <city>Pompano Beach</city>
        <state>Florida</state>
        <zip>33060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jack Herman</last_name>
      <phone>954-941-3330</phone>
      <email>jack@floridacrc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Meridien Research - St. Petersburg (Site 132)</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33709</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gigi Lefebvre</last_name>
      <phone>727-347-8839</phone>
      <email>glefebvre@meridienresearch.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Agile Clinical Research Trials, LLC (Site 163)</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30328</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Purna Cheekati</last_name>
      <phone>770-235-8479</phone>
      <email>purnacc@agilecrt.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gastrointestinal Diseases, Inc. Research (Site 137)</name>
      <address>
        <city>Columbus</city>
        <state>Georgia</state>
        <zip>31904</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pravinchandra Patel</last_name>
      <phone>888-737-7499</phone>
      <email>newtrials@serrg.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>In Quest Medical Research (Site 131)</name>
      <address>
        <city>Peachtree Corners</city>
        <state>Georgia</state>
        <zip>30071</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gul Mughal</last_name>
      <phone>770-903-0148</phone>
      <email>drgul@inquestmed.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>GNP Research (Site 145)</name>
      <address>
        <city>Valdosta</city>
        <state>Georgia</state>
        <zip>31605</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lori Smith</last_name>
      <phone>229-247-1167</phone>
      <email>lori@gnpresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwest Clinical Trials - ClinEdge (Site 133)</name>
      <address>
        <city>Boise</city>
        <state>Idaho</state>
        <zip>83704</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra Davis</last_name>
      <phone>303-399-4067</phone>
      <email>sdavis@horizonscrc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Synexus Clinical Research US, Inc. - Chicago (Site 120)</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60602</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reuben Martinez</last_name>
      <phone>312-494-2250</phone>
      <email>Reuben.Martinez@synexus-us.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Investigators Research Group, LLC (Site 188)</name>
      <address>
        <city>Brownsburg</city>
        <state>Indiana</state>
        <zip>46112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Annmarie Raphael</last_name>
      <phone>317-852-8280</phone>
      <email>araphael@investigatorsresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Synexus Clinical Research US, Inc. - Allaw (Site 102)</name>
      <address>
        <city>Evansville</city>
        <state>Indiana</state>
        <zip>47714</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georgettea Geuss</last_name>
      <phone>812-477-2760</phone>
      <email>georgettea.geuss@synexus-us.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Alliance for Multispecialty Research, LLC (Site 159)</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jill Hiebert</last_name>
      <phone>316-689-6683</phone>
      <email>jill.hiebert@amrllc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center (Site 115)</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vivian Cheng</last_name>
      <phone>617-667-0682</phone>
      <email>vcheng2@bidmc.harvard.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sundance Clinical Research (Site 175)</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>angie Kean</last_name>
      <phone>314-629-7878</phone>
      <email>akean@sundanceclinicalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Synexus Clinical Research US, Inc. - Omaha (Site 113)</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68144</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra Talbott</last_name>
      <phone>402-205-7998</phone>
      <email>Sandra.Talbott@synexus-us.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Synexus Clinical Research US, Inc. - McGill Family Practice, P.C. (Site 126)</name>
      <address>
        <city>Papillion</city>
        <state>Nebraska</state>
        <zip>68046</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Nichols</last_name>
      <phone>402-592-2055</phone>
      <email>amy.nichols@synexus-us.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jubilee Clinical Research - BTC (Site 162)</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahley Adamson</last_name>
      <phone>702-631-5000</phone>
      <email>aadamson@jcr-lv.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sierra Clinical Research (Site 179)</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maya Pudi</last_name>
      <phone>864-979-8318</phone>
      <email>maya@auroraclinicalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lovelace Scientific Resources Inc. (Site 176)</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Terry Barrett</last_name>
      <phone>505-348-9500</phone>
      <email>tebarrett@lrri.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>NY Scientific (Site 153)</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammed Hossain</last_name>
      <phone>347-547-6972</phone>
      <email>mhossain@nyscientific.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Long Island Gastrointestinal Research Group LLP (Site 107)</name>
      <address>
        <city>Great Neck</city>
        <state>New York</state>
        <zip>11023</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Toni Rende</last_name>
      <phone>516-482-5976</phone>
      <email>tonirende@ligiresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Synexus Clinical Research US, Inc. - Queens (Site 119)</name>
      <address>
        <city>Jamaica</city>
        <state>New York</state>
        <zip>11432</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabette Molina</last_name>
      <phone>718-969-3005</phone>
      <email>elizabette.molina@synexus-us.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mid Hudson Medical Research PLLC (Site 174)</name>
      <address>
        <city>Newburgh</city>
        <state>New York</state>
        <zip>12553</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dana Stivella</last_name>
      <phone>844-337-8839</phone>
      <phone_ext>705</phone_ext>
      <email>dstivella@mhmresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Upstate Clinical Research Associates LLC - ClinEdge (Site 164)</name>
      <address>
        <city>Williamsville</city>
        <state>New York</state>
        <zip>14221</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ryanne Smith</last_name>
      <phone>716-626-6320</phone>
      <email>upstateryanne@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>OnSite Clinical Solutions, LLC - ClinEdge (Site 147)</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paige Delay</last_name>
      <phone>704-247-9179</phone>
      <email>pdelay@onsiteclinical.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>OnSite Clinical Solutions, LLC - ClinEdge (Site 146)</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28277</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dorothy Starr</last_name>
      <phone>888-888-8888</phone>
      <email>dstarr@onsiteclinical.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peters Medical Research, LLC - ClinEdge (SIte 111)</name>
      <address>
        <city>High Point</city>
        <state>North Carolina</state>
        <zip>27262</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anita McPherson</last_name>
      <phone>336-883-9773</phone>
      <phone_ext>276</phone_ext>
      <email>anitam@petersmedicalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>PMG Research of Salisbury LLC (Site 110)</name>
      <address>
        <city>Salisbury</city>
        <state>North Carolina</state>
        <zip>28144</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Britschge</last_name>
      <phone>704-647-9913</phone>
      <email>mbritschge@pmg-research.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>PMG Research of Wilmington (Site 185)</name>
      <address>
        <city>Wilmington</city>
        <state>North Carolina</state>
        <zip>28401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bailey Jordan</last_name>
      <phone>910-799-5500</phone>
      <email>bailey.jordan@pmg-research.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>PMG Research of Winston-Salem (Site 124)</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Holly Smith</last_name>
      <phone>336-768-8062</phone>
      <email>holly.smith@pmg-research.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Synexus Clinical Research US, Inc. - Akron (Site 122)</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44311</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annette Robinson</last_name>
      <phone>330-252-1500</phone>
      <email>Annette.Robinson@synexus-us.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hometown Urgent Care and Research (Site 150)</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Courter</last_name>
      <phone>937-912-4444</phone>
      <email>lcourter@hometownurgentcare.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Synexus Clinical Research US, Inc. - Cincinnati (Site 127)</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45236</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Bennett</last_name>
      <phone>513-247-5577</phone>
      <email>christy.bennett@synexus-us.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Synexus Clinical Research US, Inc. - Columbus (Site 108)</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandria Culbertson</last_name>
      <phone>614-294-3854</phone>
      <email>alexandria.culbertson@synexus-us.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hometown Urgent Care and Research (Site 149)</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Belen Ayala</last_name>
      <phone>614-745-8863</phone>
      <email>bayala@hometownurgentcare.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Remington Davis Inc (Site 144)</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Botte</last_name>
      <phone>614-487-2560</phone>
      <email>jbotte@remdavis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>PriMed Clinical Research - ClinEdge (Site 121)</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45419</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zacharia Koman</last_name>
      <phone>937-291-6941</phone>
      <email>zachariah.komon@primedphysicians.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hometown Urgent Care and Research (Site 151)</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45424</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane Young</last_name>
      <phone>937-912-4386</phone>
      <email>jyoung@hometownurgentcare.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical Research international (Site 180)</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie White</last_name>
      <phone>405-702-4440</phone>
      <email>jwhite@medicalresearchintl.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tristar Clinical Investigations, P.C. (Site 168)</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Reiling</last_name>
      <phone>215-831-0445</phone>
      <email>sreiling@tristarclinical.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Frontier Clinical Research, LLC (Site 171)</name>
      <address>
        <city>Uniontown</city>
        <state>Pennsylvania</state>
        <zip>15401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cearra Appleton</last_name>
      <phone>304-216-2411</phone>
      <email>cappleton@frontierclinical.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Piedmont Research Partners LLC - BTC (Site 157)</name>
      <address>
        <city>Fort Mill</city>
        <state>South Carolina</state>
        <zip>29707</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Becky Fewell</last_name>
      <phone>803-802-4561</phone>
      <email>becky@prpstudy.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Synexus clinical Research US, Inc. - Greer (Site 105)</name>
      <address>
        <city>Greer</city>
        <state>South Carolina</state>
        <zip>29651</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miranda Williams</last_name>
      <phone>864-877-9239</phone>
      <phone_ext>239</phone_ext>
      <email>Miranda.Williams@synexus-us.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>WR-ClinSearch, LLC (Site 129)</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37421</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erica Osmundsen</last_name>
      <phone>423-698-4584</phone>
      <email>eosmundsen@clinsearch-us.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Jackson Clinic PA - ClinEdge (Site 135)</name>
      <address>
        <city>Jackson</city>
        <state>Tennessee</state>
        <zip>38305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Croom</last_name>
      <phone>731-660-8320</phone>
      <email>kcroom@jacksonclinic.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>New Phase Research &amp; Development (Site 181)</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37909</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Triebel</last_name>
      <phone>865-200-8364</phone>
      <email>hthearp@newphaseonline.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Benchmark Research - Austin (Site 178)</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78704</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lamar Box</last_name>
      <phone>512-478-5416</phone>
      <email>lamarbox@benchmarkresearch.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Advanced Medical Trials (SIte 142)</name>
      <address>
        <city>Georgetown</city>
        <state>Texas</state>
        <zip>78628</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olia Nayor</last_name>
      <phone>954-868-0901</phone>
      <email>onayor@advancedmedicaltrials.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pioneer Research Solutions (Site 125)</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77099</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Khurram Shah</last_name>
      <phone>713-333-9323</phone>
      <email>khurram@pioneerresearchsolutions.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Synergy Group US, LLC - Missouri City - Hunt (Site 156)</name>
      <address>
        <city>Missouri City</city>
        <state>Texas</state>
        <zip>77459</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meenu Varghese</last_name>
      <phone>832-500-5185</phone>
      <email>m.varghese@dmmsinc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DM Clinical Research - LinQ Research - ERN (Site 109)</name>
      <address>
        <city>Pearland</city>
        <state>Texas</state>
        <zip>77584</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mustafa Noorbhai</last_name>
      <phone>713-366-2922</phone>
      <email>mustafa@linqresearchllc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Synexus Clinical Research US, Inc. - San Antonio (Site 112)</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>48229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leticia Martinez</last_name>
      <phone>210-614-7483</phone>
      <email>Leticia.Martinez@synexus-us.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Trials of Texas Incorporated - ClinEdge (Site 134)</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Jo Perez Jenkins</last_name>
      <phone>210-949-0122</phone>
      <email>mjenkins@cttexas.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Synexus Clinical Research US, Inc. - Salt Lake City (Site 101)</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefanie Vasconez</last_name>
      <phone>385-257-2095</phone>
      <email>Stefanie.Vasconez@synexus-us.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Advanced Research Institute (Site 117)</name>
      <address>
        <city>Ogden</city>
        <state>Utah</state>
        <zip>84405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nephi Georgi</last_name>
      <phone>801-409-2040</phone>
      <email>nephi@advresearch.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Health Research of Hampton Roads Inc. (Site 173)</name>
      <address>
        <city>Newport News</city>
        <state>Virginia</state>
        <zip>23606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aesha Parikh</last_name>
      <phone>757-591-8600</phone>
      <email>aparikh@hrhr-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Center of Gastrointestinal Health (Site 152)</name>
      <address>
        <city>Petersburg</city>
        <state>Virginia</state>
        <zip>23805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samantha Morris</last_name>
      <phone>757-653-1379</phone>
      <email>samantha_morris@summitcr.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwest Clinical Research Center - ClinEdge (Site 148)</name>
      <address>
        <city>Bellevue</city>
        <state>Washington</state>
        <zip>98007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachael Hall</last_name>
      <phone>425-453-0404</phone>
      <email>rhall@nwcrc.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Exemplar Research, Inc. - Morgantown (Site 172)</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26505</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cindie Prahl</last_name>
      <phone>304-680-1585</phone>
      <email>cindie@exemplarresearchinc.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm</url>
    <description>FDA Safety Alerts and Recalls</description>
  </link>
  <link>
    <url>http://prevailibsdstudy.com</url>
    <description>For potential patients/subjects, if interested in the study, please visit this website and complete the survey</description>
  </link>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>October 15, 2019</study_first_submitted>
  <study_first_submitted_qc>October 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 17, 2019</study_first_posted>
  <last_update_submitted>July 13, 2020</last_update_submitted>
  <last_update_submitted_qc>July 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Irritable Bowel Syndrome</keyword>
  <keyword>IBS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Diarrhea</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ether</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

